Showing results (71-80 of 176) with videos related to
Sort By:
Pageof 18
Gastroenterology|February 12, 2013
Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatinChi Han Li, Ka-Fai To, Joanna Hung-Man Tong, et al.Cancer Management and Research|May 2, 2019
Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinomaLeung Li, Stephen L Chan, Frankie Mo, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 29, 2013
Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic massStephen L Chan, Frankie Mo, Philip J Johnson, et al.The Oncologist|May 27, 2018
Association Between Serum Folate Level and Toxicity of Capecitabine During Treatment for Colorectal CancerStephen L Chan, Anthony W H Chan, Frankie Mo, et al.Gastroenterology|September 28, 2019
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular CarcinomasXiaofan Ding, Mian He, Anthony W H Chan, et al.Gastroenterology|May 20, 2020
Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular CarcinomasXiaofan Ding, Mian He, Anthony W H Chan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapyStephen L Chan, Frankie K F Mo, Philip J Johnson, et al.Diseases (Basel, Switzerland)|December 24, 2025
Clinical Implications of Upregulated RSAD2 Gene Expression in Hepatocellular CarcinomaLeung Li, Nelson L S Tang, Stephen L Chan, et al.JHEP Reports : Innovation in Hepatology|April 15, 2024
A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinomaArmando Santoro, Eric Assenat, Thomas Yau, et al.Cancer|June 23, 2017
A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinomaStephen L Chan, Winnie Yeo, Frankie Mo, et al.Pageof 18